Go to Advanced Search

Showing results

110 of 203510

Article ID: 701042

Press Briefing on Recent Clinical and Preclinical Advances in Focused Ultrasound

Focused Ultrasound Foundation

A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound. Researchers and clinicians will highlight breakthrough advances in the use of focused ultrasound in cancer immunotherapy and for opening the blood-brain barrier (BBB).

Released:
25-Sep-2018 8:30 AM EDT

Channels:

Cancer, Neuro

Article ID: 701052

New State Autism Center Opens at Rutgers

Rutgers University-New Brunswick

New state autism center opens at Rutgers to improve research, treatment and family services

Released:
25-Sep-2018 7:05 AM EDT
GettyImages-820389846.jpg

Article ID: 701051

Indoor HEPA Filters Significantly Reduce Air Pollution Indoors When Outside Air is Unhealthy, New Study Finds

Intermountain Medical Center

Outdoor air pollution is a major contributor to indoor air pollution — but high-efficiency particulate air (HEPA) filters used in the home significantly reduce fine-particulate matter in the air compared with non-HEPA air filters, according to a new two-year study led by researchers at Intermountain Healthcare.

Released:
25-Sep-2018 6:00 AM EDT
Pandol_Metavert_Pancreatic092518.jpg

Article ID: 701024

New Drug Blocks Pancreatic Cancer Growth in Mice, Study Finds

Cedars-Sinai

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a study led by Cedars-Sinai. The study also demonstrated in mice that the drug, Metavert, may prevent patients from developing a resistance to currently used pancreatic cancer chemotherapies.

Released:
25-Sep-2018 5:00 AM EDT
Embargo will expire:
27-Sep-2018 4:00 AM EDT
Released to reporters:
25-Sep-2018 4:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Sep-2018 4:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

ChowAuto-CommIllustrationCreditZacGoh.jpg
  • Embargo expired:
    25-Sep-2018 1:00 AM EDT

Article ID: 700731

Harnessing Artificial Intelligence to Improve Drug Combination Design and Personalized Medicine

SLAS (Society for Laboratory Automation and Screening)

A new auto-commentary looks at how an emerging area of artificial intelligence, specifically the analysis of small systems-of-interest specific datasets, can be used to improve drug development and personalized medicine.

Released:
21-Sep-2018 5:05 AM EDT
BEN09214.jpg

Article ID: 701050

Festival partnership benefits creative arts students

University of Adelaide

The University of Adelaide has signed a major sponsorship agreement with Adelaide Festival that will connect creative arts students with some of the world’s most renowned performances.

Released:
25-Sep-2018 12:05 AM EDT

Arts and Humanities

Latinochildren-HENAMichaelRodriguez.jpg

Article ID: 701044

UCLA-led Health Equity Network of the Americas is created to address gaps in health, longevity

University of California, Los Angeles (UCLA), Health Sciences

Across the Americas, there continue to be wide gaps in health and longevity between rich and poor, educated and lesser educated, and people at high or low risk of being the targets of violence. To address these gaps, the Health Equity Network of the Americas has been launched to coincide with the release of recommendations from the Pan American Health Organization Commission on Equity and Health Inequalities in the Americas.

Released:
24-Sep-2018 7:05 PM EDT

Article ID: 701038

Limited Conclusions Can be Drawn from Study on Limiting Antithrombotic Therapy Beyond One Year for Stent Patients with Atrial Fibrillation

Cardiovascular Research Foundation (CRF)

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable coronary artery disease beyond one year after stent implantation.

Released:
24-Sep-2018 5:00 PM EDT

Showing results

110 of 203510

Chat now!